In a report released today, Bill Kerr from TD Cowen maintained a Buy rating on Chewy (CHWY – Research Report), with a price target of $45.00.

CRISPR Therapeutics (NASDAQ:CRSP) received an upgrade in its stock rating by analysts at TD Cowen, changing from Sell to Hold, while maintaining a price target of $35.00. The revision in the rating ...

TD Cowen analyst Moshe Orenbuch maintained a Hold rating on Bread Financial Holdings (BFH – Research Report) today and set a price target of ...

Neither the TSXV nor its Regulation Services Provider (as that term is defined in the policies of the Canadian Securities ...

TD Cowen analyst Jason Seidl lowered the firm’s price target on UPS (UPS) to $117 from $144 and keeps a Hold rating on the shares. The firm said its 4Q beat was overshadowed by the announcement ...

ATS (TSE:ATS – Get Free Report) had its target price cut by equities research analysts at TD Securities from C$57.00 to C$56.00 in a report released on Thursday,BayStreet.CA reports. The brokera ...

--(BUSINESS WIRE)-- CACI International Inc (NYSE: CACI) announced today that it will participate in the TD Cowen 46th Annual ... term is defined in the Private Securities Litigation Reform Act ...

Fintel reports that on January 28, 2025, TD Cowen upgraded their outlook for Roper Technologies (NasdaqGS:ROP) from Hold to Buy. Analyst Price Forecast Suggests 13.36% Upside As of December 23 ...

Enphase Energy (NASDAQ:ENPH – Get Free Report) had its price objective cut by analysts at TD Cowen from $120.00 to ... during the last quarter. Mizuho Securities USA LLC boosted its stake ...

A curated selection of the top 10 logistics and supply chain stories from 2024, reflecting key trends and themes identified by LM Group News Editor Jeff Berman—offering insights beyond popularity ...

Fintel reports that on January 17, 2025, TD Cowen upgraded their outlook for Salesforce (LSE:0QYJ) from Hold to Buy. There are 4,209 funds or institutions reporting positions in Salesforce.